Browse the evidence

Butyrate and propionate acutely stimulate the secretion of gut hormones (GLP-1, GIP, PYY) in mice, with butyrate being the most potent stimulator of anorexigenic peptides.

Acute oral administration of butyrate (400 mg/kg) in fasted mice rapidly increases levels of GLP-1, GIP, PYY, and amylin, with butyrate being the most potent stimulator of anorexigenic peptides. Propionate also stimulates GIP and amylin but not GLP-1 or PYY. Acetate has no significant acute effect on these hormones. This suggests butyrate and propionate may have distinct roles in appetite regulation via gut hormones.

Gut microbiota composition and activity influence host metabolism and immune function through mechanisms involving short-chain fatty acids (SCFAs) and bacterial endotoxins (LPS), but causal links are often confounded by environmental factors and relative abundance analysis errors.

Focus on dietary habits and lifestyle factors that support a diverse and active gut microbiome, such as consuming fermentable dietary fibers and maintaining healthy body weight. Be cautious of claims that specific single bacteria are universally 'good' or 'bad'; their effects depend on your diet and health status. Prioritize whole-food diets over isolated probiotic supplements for long-term gut health.

A higher difference between DNA methylation-predicted age and chronological age (Δage) is associated with a significantly increased risk of all-cause mortality in older adults, independent of known health and lifestyle risk factors.

Your biological age, as measured by DNA methylation patterns, may be a better predictor of your lifespan than your actual age. A higher 'epigenetic age' (meaning your DNA looks older than your chronological age) is linked to a higher risk of death, even if you don't have common diseases like diabetes or high blood pressure. While you cannot directly 'take' this biomarker, the finding suggests that maintaining health through lifestyle factors might help keep your biological age closer to your chronological age, potentially reducing mortality risk.

Sarcopenia (loss of muscle mass) is not universally associated with disability or mortality; low muscle strength is a more consistent predictor of these negative outcomes.

Don't just worry about your muscle size. Focus on maintaining your strength through resistance training. Studies show that low strength, not just low muscle mass, is what puts you at risk for disability and death. Prioritize exercises that build force production.

SGLT2 inhibitors lower blood pressure by approximately 4-6 mmHg systolic and 1-2 mmHg diastolic, primarily through plasma volume contraction and reduced arterial stiffness.

SGLT2 inhibitors provide a modest but consistent reduction in blood pressure (4-6 mmHg systolic). This effect is driven by the body excreting more sodium and water, leading to a slight contraction in blood volume and reduced stiffness in arteries.

SGLT2 inhibitors cause an acute, dose-dependent reduction in eGFR (~5 ml/min/1.73m2) and a ~30-40% reduction in albuminuria, which are protective renal hemodynamic effects rather than signs of kidney damage.

When you start an SGLT2 inhibitor, your eGFR (a measure of kidney function) may drop slightly at first. This is a normal, protective response where the kidney reduces its internal filtering pressure to prevent long-term damage. This acute drop is associated with a significant reduction in albuminuria (protein in urine) and long-term kidney protection.

Selenium's health benefits are mediated by selenoproteins, which are synthesized through a unique mechanism involving the UGA codon and the SECIS element, and these proteins play critical roles in redox regulation, thyroid hormone metabolism, and cancer prevention.

Understanding that selenium works through selenoproteins helps explain why balance is key. Too little selenium means these protective proteins aren't made, while too much can be toxic. Focus on a balanced diet to support your body's natural synthesis of these vital proteins.

EPA and DHA stabilize atherosclerotic plaques by reducing macrophage infiltration and matrix metalloproteinase (MMP) expression, thereby lowering the risk of plaque rupture.

For patients with existing atherosclerosis, EPA and DHA supplementation may help stabilize plaques by reducing inflammation within the vessel wall. This is achieved by incorporating into the plaque and reducing macrophage presence, potentially lowering the risk of rupture.

Acute elevation of plasma free fatty acids (FFA) induces insulin resistance in human skeletal muscle by inhibiting insulin-stimulated glucose transport activity, rather than glucose phosphorylation.

High levels of free fatty acids in your blood (often from high fat intake or obesity) can block insulin's ability to move glucose into your muscles. This happens because fat interferes with the insulin signaling pathway (PI 3-kinase) before glucose can be used. Managing blood fat levels through diet and exercise can help restore this sensitivity.

Elevated plasma free fatty acids blunt insulin-stimulated IRS-1–associated phosphatidylinositol 3-kinase (PI 3-kinase) activity in skeletal muscle.

High circulating fats prevent insulin from activating a key enzyme (PI 3-kinase) required for glucose uptake. This molecular blockage is a primary reason why high fat states lead to insulin resistance.

Calorie restriction extends lifespan in model organisms and mammals, and this extension requires the NAD-dependent deacetylase activity of sirtuins (specifically Sir2/SIRT1).

Calorie restriction promotes longevity, but it works through specific biological mechanisms involving sirtuins. While the paper focuses on mechanisms, the implication is that maintaining metabolic health and NAD levels is key. For humans, this suggests that dietary patterns mimicking calorie restriction (like intermittent fasting) might activate these pathways, though direct lifespan extension in humans is not yet proven.

SIRT4 regulates amino acid-stimulated insulin secretion (AASIS) by ADP-ribosylating and inhibiting glutamate dehydrogenase (GDH), linking energy limitation to insulin release.

SIRT4 helps the body decide when to release insulin in response to protein intake. During calorie restriction, SIRT4 levels drop, allowing more insulin to be released in response to amino acids, shifting the source of insulin triggers from carbohydrates to proteins.

A secular decline in occupation-related physical activity (reducing daily energy expenditure by >100 kcal) has significantly contributed to the increase in mean U.S. body weight over the last 50 years.

Your job is likely costing you weight control. Since 1960, U.S. jobs have become significantly less physically demanding, burning over 100 fewer calories per day on average. To maintain your weight, you must consciously incorporate physical activity outside of work that matches this deficit (e.g., 150 minutes of moderate activity per week), as your workplace is no longer doing it for you.

Fasting plasma ghrelin concentrations are negatively correlated with body mass index (BMI), with lower levels in obesity and higher levels in anorexia nervosa, indicating that chronic positive energy balance suppresses ghrelin secretion.

Your body's hunger hormone (ghrelin) levels are biologically tuned to your long-term weight status. In obesity, baseline ghrelin is suppressed, which may contribute to the difficulty in losing weight or maintaining loss, as the hormonal drive to eat is chronically altered. This is a physiological adaptation, not a failure of willpower.

Chronic, low-grade inflammation (inflamm-aging) driven by cytokine dysregulation, oxidative stress, and senescent cells is a primary mechanism underlying aging and age-related diseases such as cardiovascular disease, diabetes, and neurodegeneration.

Focus on lifestyle factors that reduce chronic inflammation: adopt a Mediterranean-style diet rich in omega-3s, engage in regular exercise to upregulate autophagy, and manage stress. These approaches support the body's natural resolution of inflammation rather than just suppressing symptoms.

Senescent cells contribute to aging and age-related diseases through the Senescence-Associated Secretory Phenotype (SASP), which promotes a pro-inflammatory milieu.

While direct 'senolytic' treatments are not yet standard, lifestyle factors that reduce cellular stress (exercise, healthy diet) may help minimize the accumulation of senescent cells.

Epigenetic clocks (DNAmAge) are currently the most robust biological age predictors, strongly correlating with chronological age and independently predicting all-cause mortality, cancer mortality, and various aging phenotypes such as frailty and cognitive decline.

Chronological age is not your destiny. Biomarkers like DNA methylation (epigenetic clocks) show that your body's biological state can differ significantly from your birth year. While you cannot change your birth date, these markers suggest that your health trajectory is influenced by factors like inflammation, immune function, and lifestyle. Monitoring these biological ages (where available) may offer more insight into your health risks than age alone, highlighting the importance of maintaining metabolic health and managing inflammation to potentially slow biological aging.

Elevated expression of the transcriptional coregulator Prdm16 in subcutaneous white adipose tissue induces a brown fat-like gene program, increasing energy expenditure and protecting against high-fat diet-induced obesity and glucose intolerance.

This research identifies Prdm16 as a key regulator that allows subcutaneous fat to burn energy like brown fat. While this is currently a mouse model finding, it suggests that therapies targeting this pathway could help combat obesity and insulin resistance by increasing energy expenditure. For now, maintaining a healthy weight through diet and exercise remains the primary strategy, but this mechanism highlights the importance of subcutaneous fat health.

Obesity is primarily driven by an obesogenic environment characterized by increased availability of low-cost, energy-dense foods and reduced physical activity, rather than solely by individual lack of self-control.

Focus on modifying your environment to support healthy choices. This means prioritizing access to fresh foods, reducing exposure to marketing of energy-dense processed foods, and integrating physical activity into your daily routine (e.g., walking, biking) rather than relying solely on willpower or extreme dieting. Advocate for community-level changes like safer sidewalks and healthier food options.

Low birth weight combined with rapid postnatal weight gain increases the risk of insulin resistance and type 2 diabetes in adulthood.

For those with a history of low birth weight, prioritize maintaining a healthy weight and metabolic health through balanced nutrition and physical activity to mitigate the additive risk of insulin resistance and type 2 diabetes.

Leptin-replacement therapy reduces daily caloric intake and resting metabolic rate in patients with lipodystrophy.

Leptin therapy naturally reduces hunger and metabolic rate in these patients, contributing to weight loss and metabolic improvement.

Leptin-replacement therapy reduces liver volume and improves liver function tests in patients with lipodystrophy.

Leptin therapy shrinks enlarged livers and improves liver enzymes in patients with lipodystrophy, reducing the risk of liver disease.

Adipose tissue hypoxia in obesity, driven by reduced blood perfusion rather than systemic oxygen deficiency, causes dysregulated adipocytokine production (specifically decreased adiponectin and increased PAI-1) through endoplasmic reticulum (ER) stress and mRNA instability.

Obesity creates a low-oxygen environment in fat tissue that disrupts healthy hormone production. This disruption contributes to insulin resistance and metabolic issues. While this paper doesn't offer a direct treatment, it highlights that reducing fat mass can alleviate tissue hypoxia, thereby restoring normal adipocytokine function and improving metabolic health.

Elevated triglycerides serve as a marker for increased numbers of triglyceride-rich lipoprotein (TRL) remnants, which are directly atherogenic by penetrating the arterial wall, accumulating in plaques, and promoting inflammation and thrombosis.

High triglycerides are not just a number; they represent particles that can physically enter artery walls and cause inflammation. Keeping triglycerides low (below 150 mg/dL) helps prevent these particles from building up in your arteries.